[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fsvmOmy7h2Eb-aylNKO37XqL0aGbnHSZgSrkrdHV_J4Q":8,"$fqluuXn3eJrnO-7zeNsINdroFLnarmNBPEIR5lkoJhLw":56,"$f_N3FX4yDHisdqdTDukbY-szObskgK6UdxlzjpkeQ83o":60},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":55},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":29,"seoKeywords":30,"seoDescription":31,"shelvesTime":32,"version":21,"menus":33,"menuId":35,"type":43,"quality":54,"commentCount":21,"isComment":43},19294,867154,[],"https://ystcdn.venuertc.com/medical/ystApp/9f9E1y0yGvhcutQOb47OQHSHq70WNvWa.png","王栋","涿州市医院","血液内科","主治医师",312,0,"不可忽视的杀手——弥漫大b细胞淋巴瘤","","https://cdn.yishi-tong.com/console/store-unknown/hefoPAWfp7wH35XpzT9aL4cLBRteq0Fr.png","\u003Cp style=\"margin:15px 0\">在繁忙的生活中，我们经常会忽略一些健康的警示信号。然而，有些疾病的早期症状隐匿，但一旦发展，便会对健康造成重大威胁。弥漫大B细胞淋巴瘤（DLBCL）便是这样一种疾病。本文将详细探讨这一疾病的相关知识、治疗方案和预防措施，帮助大家提高对弥漫大B细胞淋巴瘤的认识。\u003C/p>\u003Cp style=\"margin:15px 0\">弥漫大B细胞淋巴瘤是一种非霍奇金淋巴瘤，通常在50岁以上人群中较为常见。尽管其发病机制尚未完全明确，但研究表明，某些基因突变和免疫系统的异常可能与其发生有关。本文旨在为读者提供有关DLBCL的深入科普。\u003C/p>\u003Ch3 style=\"margin:20px 0\">什么是弥漫大B细胞淋巴瘤？\u003C/h3>\u003Cp style=\"margin:15px 0\">弥漫大B细胞淋巴瘤（DLBCL）是一种侵袭性较高的非霍奇金淋巴瘤，主要由异常的B细胞过度增生引起。B细胞是淋巴细胞的一种，主要负责产生抗体，保护机体免受感染。然而，当B细胞发生癌变并快速增殖时，就会导致DLBCL的发生。\u003C/p>\u003Cp style=\"margin:15px 0\">DLBCL的症状因个体差异而异，常见包括无痛性淋巴结肿大、发热、盗汗、体重减轻等。此外，特定器官的受累可能引起局部症状，例如胃肠道受累会导致腹痛或肠梗阻。\u003C/p>\u003Cp style=\"margin:15px 0\">DLBCL若不及时治疗，可能会迅速扩散至全身，侵袭骨髓、肝脏、脾脏等器官，严重时可导致器官功能衰竭。研究表明，Ⅲ期及以上的DLBCL患者预后较差，五年生存率较低。\u003C/p>\u003Ch3 style=\"margin:20px 0\">弥漫大B细胞淋巴瘤的治疗方案\u003C/h3>\u003Cp style=\"margin:15px 0\">面对DLBCL，积极的治疗可以显著改善患者的预后。常见的治疗方法包括化疗、免疫疗法、放疗和干细胞移植。\u003C/p>\u003Cp style=\"margin:15px 0\">化疗是DLBCL的主要治疗手段，通常采用的方案是R-CHOP方案，即利妥昔单抗、环磷酰胺、阿霉素、长春新碱和泼尼松的联合用药。研究表明，R-CHOP方案对DLBCL的治疗效果显著，许多患者在治疗后可达到完全缓解。\u003C/p>\u003Cp style=\"margin:15px 0\">免疫疗法是近年来治疗DLBCL的新兴疗法。CAR-T细胞疗法是一种有前景的免疫疗法，通过对患者自身的T细胞进行基因改造，使其具有识别和杀伤癌细胞的能力。临床研究表明，CAR-T细胞疗法对复发性或难治性DLBCL具有显著疗效。\u003C/p>\u003Ch3 style=\"margin:20px 0\">弥漫大B细胞淋巴瘤的预防措施\u003C/h3>\u003Cp style=\"margin:15px 0\">尽管目前没有明确的方法可以完全预防DLBCL，但通过以下措施可以降低其发病风险：\u003C/p>\u003Cp style=\"margin:15px 0\">1. 健康生活方式：保持健康的饮食习惯，戒烟限酒，避免长期暴露于有害化学物质。\u003C/p>\u003Cp style=\"margin:15px 0\">2. 定期体检：特别是高危人群，应定期进行淋巴结检查和血液检测，早期发现异常。\u003C/p>\u003Cp style=\"margin:15px 0\">3. 免疫系统维护：保持充足的睡眠，适量运动，提高免疫力，减少感染的机会。\u003C/p>\u003Cp style=\"margin:15px 0\">4. 避免长期压力：长期的心理压力可能会抑制免疫系统功能，因此应学会有效缓解压力，保持良好的心理状态。\u003C/p>\u003Ch3 style=\"margin:20px 0\">未来的医学发展如何？\u003C/h3>\u003Cp style=\"margin:15px 0\">随着医疗技术的进步，针对DLBCL的治疗手段也在不断发展。近年来，靶向药物和基因疗法的研发取得了显著进展，为患者提供了更多的治疗选择。\u003C/p>\u003Cp style=\"margin:15px 0\">然而，面对疾病，不仅需要医疗技术的支持，更需要患者自身的积极配合。罹患DLBCL的患者应保持积极的生活态度，配合医生的治疗，同时家人的支持和理解也至关重要。\u003C/p>\u003Cp style=\"margin:15px 0\"><引用文献>\u003C/p>\u003Col style=\"padding: 0 1rem;margin: 1.25rem 1rem 1.25rem 0.4rem\">\u003Cli>\u003Cp style=\"margin:15px 0\">Coiffier, B., Thieblemont, C., Van Den Neste, E., Lepeu, G., Plantier, I., Brice, P., ... & Guardiola, P. (2010). Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood, 116(12), 2040-2045.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Cheson, B. D., Fisher, R. I., Barrington, S. F., Cavalli, F., Schwartz, L. H., Zucca, E., ... & Hoffbrand, A. V. (2014). Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. Journal of clinical oncology, 32(27), 3059-3067.\u003C/p>\u003C/li>\u003Cli>\u003Cp style=\"margin:15px 0\">Schuster, S. J., Bishop, M. R., Tam, C., Borchmann, P., McGuirk, J., Jäger, U., ... & Maziarz, R. T. (2019). Tisagenlecleucel in adult relapsed or refractory diffuse large B-cell lymphoma. New England Journal of Medicine, 380(1), 45-56.\u003C/p>\u003C/li>\u003C/ol>","\n\n在繁忙的生活中，我们经常会忽略一些健康的警示信号。然而，有些疾病的早期症状隐匿，但一旦发展，便会对健康造成重大威胁。弥漫大B细胞淋巴瘤（DLBCL）便是这样一种疾病。本文将详细探讨这一疾病的相关知",555,"2025-04-09 15:27:30"," 不可忽视的杀手——弥漫大B细胞淋巴瘤：症状、诊断与治疗"," 弥漫大B细胞淋巴瘤, 淋巴瘤症状, 淋巴瘤诊断, 淋巴瘤治疗, 非霍奇金淋巴瘤"," 了解弥漫大B细胞淋巴瘤这一不可忽视的杀手，探索其症状、诊断方法和治疗选择。获取关于这种非霍奇金淋巴瘤的详细信息，帮助您更好地理解和应对这一疾病。","2025-05-16 20:08:00",[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":37,"path":38,"component":39,"isFrame":40,"isCache":41,"menuType":42,"visible":43,"status":21,"createDept":6,"remark":23,"createTime":44,"children":45,"columnImage":46,"columnLogo":47,"uncheckedLogo":6,"checkedLogo":6,"isHot":43,"isHome":21,"forceLogin":21,"color":48,"seoTitle":49,"seoKeywords":50,"seoDescription":51,"contentNum":6,"promotionalPoster":52,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":53,"routerPath":38,"componentInfo":39},"1986713082609147906","健康科普",2,"article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":57,"success":55},{"pageNo":43,"pageSize":58,"result":59,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":61,"success":55},{"authors":62,"appraiseDimensionScoresVos":63},[],[]]